HSBC Holdings’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $393K | Buy |
22,493
+9,159
| +69% | +$182K | ﹤0.01% | 2328 |
|
|
2025
Q4 | $259K | Buy |
13,334
+5,617
| +73% | +$117K | ﹤0.01% | 2584 |
|
|
2025
Q3 | $212K | Sell |
7,717
-2,479
| -24% | -$76.3K | ﹤0.01% | 2466 |
|
|
2025
Q2 | $311K | Sell |
10,196
-4,554
| -31% | -$129K | ﹤0.01% | 2414 |
|
|
2025
Q1 | $403K | Buy |
14,750
+6,902
| +88% | +$219K | ﹤0.01% | 2195 |
|
|
2024
Q4 | $282K | Buy |
+7,848
| New | +$293K | ﹤0.01% | 2530 |
|
|
2024
Q2 | – | Sell |
-7,059
| Closed | -$342K | – | 3178 |
|
|
2024
Q1 | $342K | Buy |
7,059
+647
| +10% | +$31.7K | ﹤0.01% | 2345 |
|
|
2023
Q4 | $346K | Sell |
6,412
-3,320
| -34% | -$168K | ﹤0.01% | 2216 |
|
|
2023
Q3 | $570K | Buy |
+9,732
| New | +$609K | ﹤0.01% | 1941 |
|
|
2022
Q3 | – | Sell |
-3,056
| Closed | -$220K | – | 3280 |
|
|
2022
Q2 | $220K | Sell |
3,056
-348
| -10% | -$25.9K | ﹤0.01% | 2837 |
|
|
2022
Q1 | $270K | Buy |
3,404
+1,281
| +60% | +$115K | ﹤0.01% | 2822 |
|
|
2021
Q4 | $214K | Sell |
2,123
-280
| -12% | -$27.9K | ﹤0.01% | 2998 |
|
|
2021
Q3 | $222K | Sell |
2,403
-70
| -3% | -$6.74K | ﹤0.01% | 2729 |
|
|
2021
Q2 | $254K | Buy |
2,473
+220
| +10% | +$22.1K | ﹤0.01% | 2624 |
|
|
2021
Q1 | $221K | Sell |
2,253
-2,734
| -55% | -$249K | ﹤0.01% | 2496 |
|
|
2020
Q4 | $383K | Buy |
+4,987
| New | +$386K | ﹤0.01% | 2386 |
|
|
2020
Q2 | – | Sell |
-3,563
| Closed | -$207K | – | 2874 |
|
|
2020
Q1 | $207K | Sell |
3,563
-7,540
| -68% | -$524K | ﹤0.01% | 2280 |
|
|
2019
Q4 | $873K | Buy |
+11,103
| New | +$818K | ﹤0.01% | 1910 |
|
|
2019
Q3 | – | Sell |
-26,124
| Closed | -$2.08M | – | 3163 |
|
|
2019
Q2 | $2.08M | Sell |
26,124
-28,089
| -52% | -$2.23M | ﹤0.01% | 1518 |
|
|
2019
Q1 | $4.55M | Buy |
54,213
+36,188
| +201% | +$3.78M | 0.01% | 1160 |
|
|
2018
Q4 | $2.12M | Buy |
18,025
+151
| +0.8% | +$17.5K | ﹤0.01% | 1474 |
|
|
2018
Q3 | $2.15M | Sell |
17,874
-19,758
| -53% | -$2.45M | ﹤0.01% | 1446 |
|
|
2018
Q2 | $4.33M | Sell |
37,632
-4,906
| -12% | -$537K | 0.01% | 1187 |
|
|
2018
Q1 | $3.66M | Buy |
42,538
+201
| +0.5% | +$15.6K | 0.01% | 1224 |
|
|
2017
Q4 | $3.13M | Buy |
42,337
+24,297
| +135% | +$1.63M | ﹤0.01% | 973 |
|
|
2017
Q3 | $1.04M | Hold |
18,040
| – | – | ﹤0.01% | 1479 |
|
|
2017
Q2 | $1.16M | Sell |
18,040
-34
| -0.2% | -$2.1K | ﹤0.01% | 1425 |
|
|
2017
Q1 | $1.07M | Buy |
18,074
+8,679
| +92% | +$518K | ﹤0.01% | 1393 |
|
|
2016
Q4 | $574K | Buy |
9,395
+2,079
| +28% | +$135K | ﹤0.01% | 1733 |
|
|
2016
Q3 | $505K | Hold |
7,316
| – | – | ﹤0.01% | 1565 |
|
|
2016
Q2 | $407K | Hold |
7,316
| – | – | ﹤0.01% | 1644 |
|
|
2016
Q1 | $444K | Sell |
7,316
-84
| -1% | -$4.95K | ﹤0.01% | 1587 |
|
|
2015
Q4 | $476K | Hold |
7,400
| – | – | ﹤0.01% | 1699 |
|
|
2015
Q3 | $497K | Buy |
7,400
+6,646
| +881% | +$470K | ﹤0.01% | 1407 |
|
|
2015
Q2 | $52K | Sell |
754
-13,916
| -95% | -$883K | ﹤0.01% | 1967 |
|
|
2015
Q1 | $815K | Buy |
14,670
+864
| +6% | +$44.3K | ﹤0.01% | 1401 |
|
|
2014
Q4 | $712K | Buy |
13,806
+3,340
| +32% | +$164K | ﹤0.01% | 1402 |
|
|
2014
Q3 | $385K | Buy |
10,466
+3,444
| +49% | +$124K | ﹤0.01% | 1523 |
|
|
2014
Q2 | $274K | Sell |
7,022
-16,170
| -70% | -$600K | ﹤0.01% | 1623 |
|
|
2014
Q1 | $875K | Buy |
+23,192
| New | +$810K | ﹤0.01% | 1264 |
|
Other funds holding USNA
NCM
VCM
VPM
HSBC Holdings's USNA Position: Q1 2026 in Review
HSBC Holdings increased its Usana Health Sciences (USNA) stake by 69% in Q1 2026, buying an estimated $182K and bringing the position to 22,493 shares worth $393K. The position accounts for ﹤0.01% of the portfolio, ranked #2328.
HSBC Holdings first reported a position in USNA in Q1 2014 and has held it in 40 quarters since. The position peaked at $4.55M in Q1 2019. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.
- HSBC Holdings held 22,493 shares of Usana Health Sciences worth $393K as of Q1 2026.
- HSBC Holdings bought 9,159 Usana Health Sciences shares in Q1 2026, an estimated $182K.
- Usana Health Sciences made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2328 holding.
- HSBC Holdings first reported a position in Usana Health Sciences in Q1 2014 and has held it in 40 quarters since.
- HSBC Holdings's Usana Health Sciences position peaked at $4.55M in Q1 2019.
- 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.